LeonaLY personal page - To The Moon

LeonaLY

No personal profile

3Follow

0Followers

0Topic

0Badge

2021-06-18

well said

Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal

2021-06-17

No bad

Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States

2021-06-15

Great ariticle, would you like to share it?

Cramer's Mad Money Recap: FAANG, Microsoft, PayPal

2021-04-14

Great ariticle, would you like to share it?

@mavishhs:奔跑吧！nokia[安慰]

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3573882631076090","uuid":"3573882631076090","gmtCreate":1610790174611,"gmtModify":1610790174611,"name":"LeonaLY","pinyin":"leonaly","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":168611548,"gmtCreate":1623973732984,"gmtModify":1703824956900,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"well said","listText":"well said","text":"well said","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168611548","repostId":"1121317952","repostType":4,"repost":{"id":"1121317952","pubTimestamp":1623934346,"share":"https://ttm.financial/m/news/1121317952?lang=&edition=fundamental","pubTime":"2021-06-17 20:52","market":"us","language":"en","title":"Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1121317952","media":"Reuters","summary":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity  of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.PIPE als","content":"<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.</p>\n<p>The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management &amp; Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.</p>\n<p>PIPE also includes a $200 million investment from Goldman Sachs.</p>\n<p>Mirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.</p>\n<p>Charterhouse bought Mirion in 2015 for $750 million.</p>\n<p>Mirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.</p>\n<p>GS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.</p>\n<p>SPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.</p>\n<p>Concerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.</p>\n<p>Mirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman-backed SPAC to take Mirion Tech public in $2.6 billion deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that ...</p>\n\n<a href=\"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSAH.U":"GS Acquisition Holdings Corp II"},"source_url":"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121317952","content_text":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.\nThe deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.\nPIPE also includes a $200 million investment from Goldman Sachs.\nMirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.\nCharterhouse bought Mirion in 2015 for $750 million.\nMirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.\nGS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.\nSPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.\nConcerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.\nMirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163597362,"gmtCreate":1623888227656,"gmtModify":1703822440981,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"No bad","listText":"No bad","text":"No bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163597362","repostId":"2143879474","repostType":4,"repost":{"id":"2143879474","pubTimestamp":1623853920,"share":"https://ttm.financial/m/news/2143879474?lang=&edition=fundamental","pubTime":"2021-06-16 22:32","market":"us","language":"en","title":"Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2143879474","media":"ACCESSWIRE","summary":"ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a cli","content":"<p><b>ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / </b><a href=\"https://laohu8.com/S/MOLN\">Molecular Partners AG</a> (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the pricing of its initial public offering in the United States of 3,000,000 American Depositary Shares ('ADSs') at a public offering price of $21.25 per ADS, for total gross proceeds of approximately $63.8 million. All ADSs sold in the offering were offered by Molecular Partners. Each ADS will represent <a href=\"https://laohu8.com/S/AONE\">one</a> Molecular Partners ordinary share. The new ordinary shares underlying the ADSs will be issued from Molecular Partners' authorized capital under exclusion of the existing shareholders' pre-emptive rights. In addition, Molecular Partners has granted the underwriters a 30-day option to purchase up to an additional 450,000 ADSs at the initial public offering price, less underwriting discounts and commissions.</p>\n<p>Trading of the ADSs is expected to commence on The Nasdaq Global Select Market on Wednesday, June 16, 2021 under the ticker symbol 'MOLN.' SIX Swiss Exchange ('SIX') approved the listing of the new ordinary shares underlying the ADSs as of June 17, 2021.</p>\n<p>On June 16, 2021, trading of the existing shares of Molecular Partners on SIX will be halted. If trading of the ADS on the Nasdaq will commence at 4 p.m. CEST on June 16, 2021 or any time before, trading of the shares of Molecular Partners on SIX will reopen on the same day. If trading on the Nasdaq starts later, trading of the shares in Molecular Partners on SIX will reopen on June 17, 2021 only.</p>\n<p>The offering is expected to close on or about June 18, 2021, subject to customary closing conditions.</p>\n<p>J.P. Morgan, SVB Leerink and Cowen are acting as joint book-running managers for the proposed offering. RBC Capital Markets is acting as the bookrunner for the proposed offering. Kempen &amp; Co is acting as the lead manager for the proposed offering.</p>\n<p>A registration statement on Form F-1 relating to these securities became effective on June 15, 2021. The securities referred to in this release are to be offered only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a written copy may be obtained for free from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-866-803-9204; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at 1-800-808-7525, ext. 6105, or by e-mailing syndicate@svbleerink.com; Cowen and Company, LLC (c/o Broadridge Financial Services), 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com. The securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. In connection with the listing of the ordinary shares on the SIX, the registration statement on Form F-1 constitutes a foreign prospectus within the meaning of article 54 paras. 2 and 3 of the Swiss Financial Services Act of June 15, 2018 ('FinSA') and article 70 paras. 2-4 of the Swiss Financial Services Ordinance of November 6, 2019 ('FinSO'). The registration statement on Form F-1, including the preliminary prospectus, as well as the final prospectus, once available, will be deposited with the Prospectus Office of SIX Exchange Regulation. Further, the inclusion of the foreign prospectus in the prospectus list published by the Prospectus Office of SIX Exchange Regulation will be requested.</p>\n<p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. There is no intention or permission to publicly offer, solicit, sell or advertise, directly or indirectly, any securities of Molecular Partners in or into Switzerland within the meaning of FinSA.</p>\n<h4>About Molecular Partners AG</h4>\n<p>Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMolecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® ...</p>\n\n<a href=\"https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AFG":"美国金融集团有限公司","00626":"大众金融控股","UBCP":"联合合众银行","MOLN":"Molecular Partners AG","00467":"联合能源集团"},"source_url":"https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143879474","content_text":"ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the pricing of its initial public offering in the United States of 3,000,000 American Depositary Shares ('ADSs') at a public offering price of $21.25 per ADS, for total gross proceeds of approximately $63.8 million. All ADSs sold in the offering were offered by Molecular Partners. Each ADS will represent one Molecular Partners ordinary share. The new ordinary shares underlying the ADSs will be issued from Molecular Partners' authorized capital under exclusion of the existing shareholders' pre-emptive rights. In addition, Molecular Partners has granted the underwriters a 30-day option to purchase up to an additional 450,000 ADSs at the initial public offering price, less underwriting discounts and commissions.\nTrading of the ADSs is expected to commence on The Nasdaq Global Select Market on Wednesday, June 16, 2021 under the ticker symbol 'MOLN.' SIX Swiss Exchange ('SIX') approved the listing of the new ordinary shares underlying the ADSs as of June 17, 2021.\nOn June 16, 2021, trading of the existing shares of Molecular Partners on SIX will be halted. If trading of the ADS on the Nasdaq will commence at 4 p.m. CEST on June 16, 2021 or any time before, trading of the shares of Molecular Partners on SIX will reopen on the same day. If trading on the Nasdaq starts later, trading of the shares in Molecular Partners on SIX will reopen on June 17, 2021 only.\nThe offering is expected to close on or about June 18, 2021, subject to customary closing conditions.\nJ.P. Morgan, SVB Leerink and Cowen are acting as joint book-running managers for the proposed offering. RBC Capital Markets is acting as the bookrunner for the proposed offering. Kempen & Co is acting as the lead manager for the proposed offering.\nA registration statement on Form F-1 relating to these securities became effective on June 15, 2021. The securities referred to in this release are to be offered only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a written copy may be obtained for free from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-866-803-9204; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at 1-800-808-7525, ext. 6105, or by e-mailing syndicate@svbleerink.com; Cowen and Company, LLC (c/o Broadridge Financial Services), 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com. The securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. In connection with the listing of the ordinary shares on the SIX, the registration statement on Form F-1 constitutes a foreign prospectus within the meaning of article 54 paras. 2 and 3 of the Swiss Financial Services Act of June 15, 2018 ('FinSA') and article 70 paras. 2-4 of the Swiss Financial Services Ordinance of November 6, 2019 ('FinSO'). The registration statement on Form F-1, including the preliminary prospectus, as well as the final prospectus, once available, will be deposited with the Prospectus Office of SIX Exchange Regulation. Further, the inclusion of the foreign prospectus in the prospectus list published by the Prospectus Office of SIX Exchange Regulation will be requested.\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. There is no intention or permission to publicly offer, solicit, sell or advertise, directly or indirectly, any securities of Molecular Partners in or into Switzerland within the meaning of FinSA.\nAbout Molecular Partners AG\nMolecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187663786,"gmtCreate":1623752448645,"gmtModify":1704210516576,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187663786","repostId":"1191265676","repostType":4,"repost":{"id":"1191265676","pubTimestamp":1623748736,"share":"https://ttm.financial/m/news/1191265676?lang=&edition=fundamental","pubTime":"2021-06-15 17:18","market":"us","language":"en","title":"Cramer's Mad Money Recap: FAANG, Microsoft, PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=1191265676","media":"The Street","summary":"Jim Cramer says investors should think of this market as a supermarket, where smart stock shoppers c","content":"<blockquote>\n Jim Cramer says investors should think of this market as a supermarket, where smart stock shoppers can pick from among the best values available.\n</blockquote>\n<p>Investors can expect more days like today, days where some stocks are red hot while others are dropping like a stone, Jim Cramer told his Mad Money viewers Monday.</p>\n<p>Until we hear what the Federal Reserve has planned on Wednesday, Cramer said investors are likely to continue dumping the industrials and the banks in favor of the secular growth names.</p>\n<p>The stock market is indeed a market, after all, one made up of thousands of different stocks. That means it rarely trades as a single entity, Cramer reminded viewers. But before you pass the \"buy\" button on your favorite growth stock, Cramer reminded viewers that not all growth is the same.</p>\n<p>Down one shopping aisle are what Cramer dubbed the senior growth stocks, tried-and-true names like FAANG (Cramer's acronym for Facebook&nbsp;(<b>FB</b>) , Amazon&nbsp;(<b>AMZN</b>) , Apple&nbsp;(<b>AAPL</b>) Netflix&nbsp;(<b>NFLX</b>) &nbsp;and Alphabet&nbsp;(<b>GOOGL</b>) , along with Microsoft&nbsp;(<b>MSFT</b>) , Adobe Systems&nbsp;(<b>ADBE</b>) , Square&nbsp;(<b>SQ</b>) and PayPal&nbsp;(<b>PYPL</b>). On another aisle in this market are the junior growth names like Twilio&nbsp;(<b>TWLO</b>), Roku&nbsp;(<b>ROKU</b>), Etsy&nbsp;(<b>ETSY</b>)&nbsp;and DocuSign&nbsp;(<b>DOCU</b>). Cramer remains a believer in the senior names, but felt the junior names may be risky.</p>\n<p>Likewise, Cramer said he's not willing to give up on growth with steelmakers, miners and oil. That's because even if the U.S. taps the brakes on interest rates, which he doesn't think will happen, the rest of the world still has a lot of growth ahead in the coming months.</p>\n<p>In Cramer's view, the Fed is willing to sacrifice a little inflation if it means creating jobs and putting more people to work. That's a recipe for lots of sectors to continue their rally to new record highs.</p>\n<p>Cramer and the AAP team are looking at everything from earnings and politics to the Federal Reserve.</p>\n<p><b>Off the Charts: Independence Day Patterns</b></p>\n<p>In the \"Off The Charts\" segment, Cramer checked in with colleague Larry Williams for another take on the direction of the markets. This time, Williams looked at the market through the prism of the seasonal July 4 patterns.</p>\n<p>Williams noted that the last week of June is historically the worst time to sell stocks, as they always sell off during that week. The week before however, specifically the 8th or 9th last trading day of the month, has proven to be a winner. This year, those days would be Friday, June 18 or Monday, June 21.</p>\n<p>As for buying them your stocks back, Williams said that five days later is the sweet spot, or the first day after the holiday that the market trades higher.</p>\n<p>This strategy has been a winner 21 of the past 22 years.</p>\n<p><b>Executive Decision: American Express</b></p>\n<p>In his first \"Executive Decision\" segment, Cramer spoke with Steve Squeri, chairman and CEO of American Express&nbsp;(<b>AXP</b>), which has rallied 38% so far this year.</p>\n<p>Squeri said the consumer is looking a lot better than we expected coming out of the pandemic. Credit debt is down, personal savings are up and there's a lot of pent up demand to get out and spend. Even in the beleaguered travel industry, Squeri reported that May 2021's bookings are 95% of what they were in May 2019.</p>\n<p>American Express is evolving into a lifestyle, Squeri added, and that's good for millennials that want access and experiences, both of which American Express can provide.</p>\n<p>Turning to the topic of small businesses, Squeri noted that small businesses also love American Express and thanks to their recent acquisition of Cabbage, a digital cash management platform, they can now provide more services to business than ever before.</p>\n<p>American Express is also working hard to support minority-owned businesses. Squeri said that they offer access to capital, grant, mentoring and leadership training to minority businesses.</p>\n<p>On<b>Real Money</b>, Cramer keys in on the companies and CEOs he knows best.</p>\n<p><b>Off the Tape:&nbsp;Solana Labs</b></p>\n<p>In his \"Off The Tape\" segment, Cramer spoke with Anatoly Yakovenko, co-founder and CEO of the privately-held Solana Labs, which just raised $314 million to bring the next generation cryptocurrency applications to market.</p>\n<p>Yakovenko explained that while blockchain technologies are revolutionary, the systems they're currently built on are way too slow to keep up with their growth. Many of the transactions happening today are running on technology that's more than 10 years old.</p>\n<p>Solana's systems are optimized for today's technologies, Yakovenko said. They aim to provide services that are \"blockchain at the speed of Nasdaq.\" Solana's platform is already clocking in at 65,000 transactions per second, on par with Visa's&nbsp;(<b>V</b>) &nbsp;processing capabilities.</p>\n<p>Solana is still in startup mode with no earnings to speak of, Yakovenko said, but every day developers are switching to Solana's platform and building their applications, so it won't be long before growth begins to accelerate.</p>\n<p><b>What's the Point?</b></p>\n<p>Think you're \"sticking it to the man\" with your portfolio? If so, Cramer said if you're likely just hurting yourself.</p>\n<p>Case in point: Corsair Gaming&nbsp;(<b>CRSR</b>), the high-end peripheral maker. Shares surged in early trading after being mentioned on WallStreetBets, only to have the short sellers swoop in and erase most of those gains by the close. Cramer said if you bought shares over $40, you got hurt big time. But that's what happens when you follow a meme.</p>\n<p>Sure, Corsair has a great quarter this time around, but does the stock have the staying power to support these levels? Probably not. By comparison, long-time Cramer favorite Logitech&nbsp;(<b>LOGI</b>)&nbsp;also makes gaming peripherals and that company has proven it has staying power both in the home and in the workplace.</p>\n<p><b>Lightning Round</b></p>\n<p>Here's what Cramer had to say about some of the stocks that callers offered up during the \"Mad Money Lightning Round\" Monday evening:</p>\n<p>Johnson &amp; Johnson&nbsp;(<b>JNJ</b>): \"This stock has a big development pipeline and that's why it keeps going up.\"</p>\n<p>Lockheed Martin&nbsp;(<b>LMT</b>): \"I think this one is money. I say go with it.\"</p>\n<p>Vulcan Materials&nbsp;(<b>VMC</b>): \"This one has a bad chart but, boy, is that a good company. \"</p>\n<p>ViacomCBS&nbsp;(<b>VIACA</b>): \"I kinda like the media stocks. I think they're going to have a good Fall season.\"</p>\n<p>OraSure Technologies&nbsp;(<b>OSUR</b>): \"There are so many at-home test kits now. No, I can't recommend it.\"</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cramer's Mad Money Recap: FAANG, Microsoft, PayPal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCramer's Mad Money Recap: FAANG, Microsoft, PayPal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 17:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-june-14-2021><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Jim Cramer says investors should think of this market as a supermarket, where smart stock shoppers can pick from among the best values available.\n\nInvestors can expect more days like today, days where...</p>\n\n<a href=\"https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-june-14-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ETSY":"Etsy, Inc.","ROKU":"Roku Inc","V":"Visa","AAPL":"苹果","MSFT":"微软","AXP":"美国运通","PYPL":"PayPal","ADBE":"Adobe","NFLX":"奈飞","SQ":"Block","TWLO":"Twilio Inc","CRSR":"Corsair Gaming, Inc.","DOCU":"Docusign","AMZN":"亚马逊","LOGI":"罗技"},"source_url":"https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-june-14-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191265676","content_text":"Jim Cramer says investors should think of this market as a supermarket, where smart stock shoppers can pick from among the best values available.\n\nInvestors can expect more days like today, days where some stocks are red hot while others are dropping like a stone, Jim Cramer told his Mad Money viewers Monday.\nUntil we hear what the Federal Reserve has planned on Wednesday, Cramer said investors are likely to continue dumping the industrials and the banks in favor of the secular growth names.\nThe stock market is indeed a market, after all, one made up of thousands of different stocks. That means it rarely trades as a single entity, Cramer reminded viewers. But before you pass the \"buy\" button on your favorite growth stock, Cramer reminded viewers that not all growth is the same.\nDown one shopping aisle are what Cramer dubbed the senior growth stocks, tried-and-true names like FAANG (Cramer's acronym for Facebook (FB) , Amazon (AMZN) , Apple (AAPL) Netflix (NFLX)  and Alphabet (GOOGL) , along with Microsoft (MSFT) , Adobe Systems (ADBE) , Square (SQ) and PayPal (PYPL). On another aisle in this market are the junior growth names like Twilio (TWLO), Roku (ROKU), Etsy (ETSY) and DocuSign (DOCU). Cramer remains a believer in the senior names, but felt the junior names may be risky.\nLikewise, Cramer said he's not willing to give up on growth with steelmakers, miners and oil. That's because even if the U.S. taps the brakes on interest rates, which he doesn't think will happen, the rest of the world still has a lot of growth ahead in the coming months.\nIn Cramer's view, the Fed is willing to sacrifice a little inflation if it means creating jobs and putting more people to work. That's a recipe for lots of sectors to continue their rally to new record highs.\nCramer and the AAP team are looking at everything from earnings and politics to the Federal Reserve.\nOff the Charts: Independence Day Patterns\nIn the \"Off The Charts\" segment, Cramer checked in with colleague Larry Williams for another take on the direction of the markets. This time, Williams looked at the market through the prism of the seasonal July 4 patterns.\nWilliams noted that the last week of June is historically the worst time to sell stocks, as they always sell off during that week. The week before however, specifically the 8th or 9th last trading day of the month, has proven to be a winner. This year, those days would be Friday, June 18 or Monday, June 21.\nAs for buying them your stocks back, Williams said that five days later is the sweet spot, or the first day after the holiday that the market trades higher.\nThis strategy has been a winner 21 of the past 22 years.\nExecutive Decision: American Express\nIn his first \"Executive Decision\" segment, Cramer spoke with Steve Squeri, chairman and CEO of American Express (AXP), which has rallied 38% so far this year.\nSqueri said the consumer is looking a lot better than we expected coming out of the pandemic. Credit debt is down, personal savings are up and there's a lot of pent up demand to get out and spend. Even in the beleaguered travel industry, Squeri reported that May 2021's bookings are 95% of what they were in May 2019.\nAmerican Express is evolving into a lifestyle, Squeri added, and that's good for millennials that want access and experiences, both of which American Express can provide.\nTurning to the topic of small businesses, Squeri noted that small businesses also love American Express and thanks to their recent acquisition of Cabbage, a digital cash management platform, they can now provide more services to business than ever before.\nAmerican Express is also working hard to support minority-owned businesses. Squeri said that they offer access to capital, grant, mentoring and leadership training to minority businesses.\nOnReal Money, Cramer keys in on the companies and CEOs he knows best.\nOff the Tape: Solana Labs\nIn his \"Off The Tape\" segment, Cramer spoke with Anatoly Yakovenko, co-founder and CEO of the privately-held Solana Labs, which just raised $314 million to bring the next generation cryptocurrency applications to market.\nYakovenko explained that while blockchain technologies are revolutionary, the systems they're currently built on are way too slow to keep up with their growth. Many of the transactions happening today are running on technology that's more than 10 years old.\nSolana's systems are optimized for today's technologies, Yakovenko said. They aim to provide services that are \"blockchain at the speed of Nasdaq.\" Solana's platform is already clocking in at 65,000 transactions per second, on par with Visa's (V)  processing capabilities.\nSolana is still in startup mode with no earnings to speak of, Yakovenko said, but every day developers are switching to Solana's platform and building their applications, so it won't be long before growth begins to accelerate.\nWhat's the Point?\nThink you're \"sticking it to the man\" with your portfolio? If so, Cramer said if you're likely just hurting yourself.\nCase in point: Corsair Gaming (CRSR), the high-end peripheral maker. Shares surged in early trading after being mentioned on WallStreetBets, only to have the short sellers swoop in and erase most of those gains by the close. Cramer said if you bought shares over $40, you got hurt big time. But that's what happens when you follow a meme.\nSure, Corsair has a great quarter this time around, but does the stock have the staying power to support these levels? Probably not. By comparison, long-time Cramer favorite Logitech (LOGI) also makes gaming peripherals and that company has proven it has staying power both in the home and in the workplace.\nLightning Round\nHere's what Cramer had to say about some of the stocks that callers offered up during the \"Mad Money Lightning Round\" Monday evening:\nJohnson & Johnson (JNJ): \"This stock has a big development pipeline and that's why it keeps going up.\"\nLockheed Martin (LMT): \"I think this one is money. I say go with it.\"\nVulcan Materials (VMC): \"This one has a bad chart but, boy, is that a good company. \"\nViacomCBS (VIACA): \"I kinda like the media stocks. I think they're going to have a good Fall season.\"\nOraSure Technologies (OSUR): \"There are so many at-home test kits now. No, I can't recommend it.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":344503992,"gmtCreate":1618412912516,"gmtModify":1704710518393,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344503992","repostId":"344289682","repostType":1,"repost":{"id":344289682,"gmtCreate":1618410139546,"gmtModify":1704710436163,"author":{"id":"3570762430883798","authorId":"3570762430883798","name":"mavishhs","avatar":"https://static.tigerbbs.com/b49fbc4c03077f7d07a05e5bdadc632f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570762430883798","authorIdStr":"3570762430883798"},"themes":[],"htmlText":"奔跑吧！nokia[安慰]&nbsp;","listText":"奔跑吧！nokia[安慰]&nbsp;","text":"奔跑吧！nokia[安慰]","images":[{"img":"https://static.tigerbbs.com/5fcc67c12ef9be76a7f4708297bea22f","width":"1080","height":"3093"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344289682","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":168611548,"gmtCreate":1623973732984,"gmtModify":1703824956900,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"well said","listText":"well said","text":"well said","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168611548","repostId":"1121317952","repostType":4,"repost":{"id":"1121317952","pubTimestamp":1623934346,"share":"https://ttm.financial/m/news/1121317952?lang=&edition=fundamental","pubTime":"2021-06-17 20:52","market":"us","language":"en","title":"Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1121317952","media":"Reuters","summary":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity  of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.PIPE als","content":"<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.</p>\n<p>The deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management &amp; Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.</p>\n<p>PIPE also includes a $200 million investment from Goldman Sachs.</p>\n<p>Mirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.</p>\n<p>Charterhouse bought Mirion in 2015 for $750 million.</p>\n<p>Mirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.</p>\n<p>GS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.</p>\n<p>SPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.</p>\n<p>Concerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.</p>\n<p>Mirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman-backed SPAC to take Mirion Tech public in $2.6 billion deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman-backed SPAC to take Mirion Tech public in $2.6 billion deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that ...</p>\n\n<a href=\"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GSAH.U":"GS Acquisition Holdings Corp II"},"source_url":"https://wwww.reuters.com/article/mirion-tech-ma-gs-acquisition/update-1-goldman-backed-spac-to-take-mirion-tech-public-in-2-6-bln-deal-idUSL3N2NZ354","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121317952","content_text":"-Radiation detection provider Mirion Technologies Inc said on Thursday it will go public through a merger with a Goldman Sachs Group Inc-backed special purpose acquisition company, in a deal that values the combined entity at $2.6 billion.\nThe deal with GS Acquisition Holdings Corp II will be supported by a private investment in public equity (PIPE) of $900 million from investors such as Fidelity Management & Research Company LLC, BlackRock, Neuberger Berman funds and Janus Henderson Investors.\nPIPE also includes a $200 million investment from Goldman Sachs.\nMirion is owned by London-based private equity firm Charterhouse Capital Partners, which revived a sale of the company earlier this year after halting a previous attempt in 2019, according to a report by Bloomberg.\nCharterhouse bought Mirion in 2015 for $750 million.\nMirion has pursued a string of acquisitions to expand its gamut of services that include detection, measurement and analysis solutions to the nuclear, defence, medical end markets. Its most recent acquisitions include Germany-based Dosimetrics GmbH and Sun Nuclear Corp.\nGS Acquisition, a special purpose acquisition company (SPAC), went public in a $700 million IPO in June last year.\nSPACs are shell companies which raise funds through an initial public offering to take a private company public through a merger at a later date.\nConcerns that SPACs have taken pre-revenue, loss-making electric vehicle makers public at very high valuations have turned PIPE investors away in recent weeks.\nMirion will list on the New York Stock Exchange under the ticker symbol “MIR”, after the deal closes in the second half of the year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163597362,"gmtCreate":1623888227656,"gmtModify":1703822440981,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"No bad","listText":"No bad","text":"No bad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/163597362","repostId":"2143879474","repostType":4,"repost":{"id":"2143879474","pubTimestamp":1623853920,"share":"https://ttm.financial/m/news/2143879474?lang=&edition=fundamental","pubTime":"2021-06-16 22:32","market":"us","language":"en","title":"Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2143879474","media":"ACCESSWIRE","summary":"ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a cli","content":"<p><b>ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / </b><a href=\"https://laohu8.com/S/MOLN\">Molecular Partners AG</a> (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the pricing of its initial public offering in the United States of 3,000,000 American Depositary Shares ('ADSs') at a public offering price of $21.25 per ADS, for total gross proceeds of approximately $63.8 million. All ADSs sold in the offering were offered by Molecular Partners. Each ADS will represent <a href=\"https://laohu8.com/S/AONE\">one</a> Molecular Partners ordinary share. The new ordinary shares underlying the ADSs will be issued from Molecular Partners' authorized capital under exclusion of the existing shareholders' pre-emptive rights. In addition, Molecular Partners has granted the underwriters a 30-day option to purchase up to an additional 450,000 ADSs at the initial public offering price, less underwriting discounts and commissions.</p>\n<p>Trading of the ADSs is expected to commence on The Nasdaq Global Select Market on Wednesday, June 16, 2021 under the ticker symbol 'MOLN.' SIX Swiss Exchange ('SIX') approved the listing of the new ordinary shares underlying the ADSs as of June 17, 2021.</p>\n<p>On June 16, 2021, trading of the existing shares of Molecular Partners on SIX will be halted. If trading of the ADS on the Nasdaq will commence at 4 p.m. CEST on June 16, 2021 or any time before, trading of the shares of Molecular Partners on SIX will reopen on the same day. If trading on the Nasdaq starts later, trading of the shares in Molecular Partners on SIX will reopen on June 17, 2021 only.</p>\n<p>The offering is expected to close on or about June 18, 2021, subject to customary closing conditions.</p>\n<p>J.P. Morgan, SVB Leerink and Cowen are acting as joint book-running managers for the proposed offering. RBC Capital Markets is acting as the bookrunner for the proposed offering. Kempen &amp; Co is acting as the lead manager for the proposed offering.</p>\n<p>A registration statement on Form F-1 relating to these securities became effective on June 15, 2021. The securities referred to in this release are to be offered only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a written copy may be obtained for free from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-866-803-9204; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at 1-800-808-7525, ext. 6105, or by e-mailing syndicate@svbleerink.com; Cowen and Company, LLC (c/o Broadridge Financial Services), 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com. The securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. In connection with the listing of the ordinary shares on the SIX, the registration statement on Form F-1 constitutes a foreign prospectus within the meaning of article 54 paras. 2 and 3 of the Swiss Financial Services Act of June 15, 2018 ('FinSA') and article 70 paras. 2-4 of the Swiss Financial Services Ordinance of November 6, 2019 ('FinSO'). The registration statement on Form F-1, including the preliminary prospectus, as well as the final prospectus, once available, will be deposited with the Prospectus Office of SIX Exchange Regulation. Further, the inclusion of the foreign prospectus in the prospectus list published by the Prospectus Office of SIX Exchange Regulation will be requested.</p>\n<p>This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. There is no intention or permission to publicly offer, solicit, sell or advertise, directly or indirectly, any securities of Molecular Partners in or into Switzerland within the meaning of FinSA.</p>\n<h4>About Molecular Partners AG</h4>\n<p>Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Molecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMolecular Partners Announces Pricing of Initial Public Offering of American Depositary Shares in the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 22:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® ...</p>\n\n<a href=\"https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AFG":"美国金融集团有限公司","00626":"大众金融控股","UBCP":"联合合众银行","MOLN":"Molecular Partners AG","00467":"联合能源集团"},"source_url":"https://finance.yahoo.com/news/molecular-partners-announces-pricing-initial-020000537.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143879474","content_text":"ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 15, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the pricing of its initial public offering in the United States of 3,000,000 American Depositary Shares ('ADSs') at a public offering price of $21.25 per ADS, for total gross proceeds of approximately $63.8 million. All ADSs sold in the offering were offered by Molecular Partners. Each ADS will represent one Molecular Partners ordinary share. The new ordinary shares underlying the ADSs will be issued from Molecular Partners' authorized capital under exclusion of the existing shareholders' pre-emptive rights. In addition, Molecular Partners has granted the underwriters a 30-day option to purchase up to an additional 450,000 ADSs at the initial public offering price, less underwriting discounts and commissions.\nTrading of the ADSs is expected to commence on The Nasdaq Global Select Market on Wednesday, June 16, 2021 under the ticker symbol 'MOLN.' SIX Swiss Exchange ('SIX') approved the listing of the new ordinary shares underlying the ADSs as of June 17, 2021.\nOn June 16, 2021, trading of the existing shares of Molecular Partners on SIX will be halted. If trading of the ADS on the Nasdaq will commence at 4 p.m. CEST on June 16, 2021 or any time before, trading of the shares of Molecular Partners on SIX will reopen on the same day. If trading on the Nasdaq starts later, trading of the shares in Molecular Partners on SIX will reopen on June 17, 2021 only.\nThe offering is expected to close on or about June 18, 2021, subject to customary closing conditions.\nJ.P. Morgan, SVB Leerink and Cowen are acting as joint book-running managers for the proposed offering. RBC Capital Markets is acting as the bookrunner for the proposed offering. Kempen & Co is acting as the lead manager for the proposed offering.\nA registration statement on Form F-1 relating to these securities became effective on June 15, 2021. The securities referred to in this release are to be offered only by means of a prospectus. Copies of the final prospectus relating to the offering may be obtained, when available, for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, a written copy may be obtained for free from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-866-803-9204; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at 1-800-808-7525, ext. 6105, or by e-mailing syndicate@svbleerink.com; Cowen and Company, LLC (c/o Broadridge Financial Services), 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, by telephone at (833) 297-2926 or by email at PostSaleManualRequests@broadridge.com. The securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. In connection with the listing of the ordinary shares on the SIX, the registration statement on Form F-1 constitutes a foreign prospectus within the meaning of article 54 paras. 2 and 3 of the Swiss Financial Services Act of June 15, 2018 ('FinSA') and article 70 paras. 2-4 of the Swiss Financial Services Ordinance of November 6, 2019 ('FinSO'). The registration statement on Form F-1, including the preliminary prospectus, as well as the final prospectus, once available, will be deposited with the Prospectus Office of SIX Exchange Regulation. Further, the inclusion of the foreign prospectus in the prospectus list published by the Prospectus Office of SIX Exchange Regulation will be requested.\nThis press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. There is no intention or permission to publicly offer, solicit, sell or advertise, directly or indirectly, any securities of Molecular Partners in or into Switzerland within the meaning of FinSA.\nAbout Molecular Partners AG\nMolecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":187663786,"gmtCreate":1623752448645,"gmtModify":1704210516576,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/187663786","repostId":"1191265676","repostType":4,"isVote":1,"tweetType":1,"viewCount":200,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":344503992,"gmtCreate":1618412912516,"gmtModify":1704710518393,"author":{"id":"3573882631076090","authorId":"3573882631076090","name":"LeonaLY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573882631076090","authorIdStr":"3573882631076090"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344503992","repostId":"344289682","repostType":1,"repost":{"id":344289682,"gmtCreate":1618410139546,"gmtModify":1704710436163,"author":{"id":"3570762430883798","authorId":"3570762430883798","name":"mavishhs","avatar":"https://static.tigerbbs.com/b49fbc4c03077f7d07a05e5bdadc632f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3570762430883798","authorIdStr":"3570762430883798"},"themes":[],"htmlText":"奔跑吧！nokia[安慰]&nbsp;","listText":"奔跑吧！nokia[安慰]&nbsp;","text":"奔跑吧！nokia[安慰]","images":[{"img":"https://static.tigerbbs.com/5fcc67c12ef9be76a7f4708297bea22f","width":"1080","height":"3093"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344289682","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}